The other big issue is this whole question on dose management. And Bayer Healthcare bought Medtronic several years ago, and now they’ve acquired Radimetrics [the Toronto, Ont.-based Radimetrics], the leading company in the dose tracking and management area, and they’re promoting their capability as total dose management.
There has been a lot of discussion this year about dose tracking and management. I’m wondering where exactly that capability will sit, in relation to other capabilities and tools? Will it be an independently provided tool, or will it be integrated into the RIS [radiology information system] architecture?
I think Siemens [the Malvern, Pa.-based Siemens Healthcare] provides a prime example of how that might work; they bought the toolkit from Radimetrics and put it under the covers as their own tool, just as they did with Nuance with voice recognition. Also, the dose management element interfaces with the modality, and the analytics element interfaces with the RIS.
So will the larger vendors create their own under-the-covers capability in this area, then?
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.